George Allen Hides

George Allen Hides has a diverse work experience in the healthcare and medical field. George Allen has held various roles in different companies and organizations.

From 1990 to 1994, George worked at Michael Reese Hospital and Medical Center as a Scientific Member of the Bioethics Committee and as the Chief of the Vascular Surgery Laboratory in the Department of Surgery.

Between 1995 and 1999, they served as a Clinical Research and Basic Science Laboratory Research Associate at Northfield Laboratories Inc. and Denver General Hospital, Department of Surgery, under the supervision of E.E. Moore MD FACS, the Chief of the Department of Surgery, Trauma, and Critical Care.

In 1999, George became the Vice President of Clinical and Regulatory Affairs at Northfield Laboratories Inc., where they played a crucial role in developing a polymerized hemoglobin-based oxygen-carrying blood substitute called PolyHeme.

George's next role was at Rush University, where they worked as an Instructor in Vascular/US Physics in the Department of Medical Physics and Advanced Imaging from 2002 onwards. Additionally, they served as an Academic Advisory Board Member for the same department, contributing to Rush University's mission of providing high-quality healthcare and education.

In 2011, George joined the Chicago Innovation Mentors at MATTER as the CIM Lead Mentor, offering guidance and support to early-stage innovators in the biomedical and healthcare fields. George Allen also took on the role of CIMposia Program Director, organizing networking and educational events for life-science startups.

In 2009, George founded Geis-Hides Consulting LLC (GHC), a consulting firm that provides clinical and regulatory development solutions for biologics and pharmaceutical compounds. Until now, they have been serving as the Managing Partner at GHC.

George's most recent position is at physIQ, where they have been working since 2017 as the Vice President of Regulatory and Clinical Affairs. physIQ specializes in personalized care delivery models using its data analytics platform to detect early signs of disease exacerbation or changes in health.

In the same year, George also became the Vice President of Regulatory Affairs and Operations at KaloCyte, Inc., a company focused on developing a dried artificial red blood cell called ErythroMer.

Overall, George Allen Hides has extensive experience in regulatory affairs, clinical development, and consultancy in the healthcare industry, as well as a strong academic background in medical physics and vascular surgery.

George Allen Hides completed their Bachelor of Arts degree in Physics and Religion at DePauw University in 1990.